Nice exercise... the issues as I see them:
How much will be saved, treatment time, facilities, equipment, by Leronlimab?
A friend of mine has been on a ventilator for over six weeks now. I've been trying for months to get his spouse to insist on Leronlimab but she's allowing the doctors to dismiss her... had they gotten an EIND back in April, how much time and resources would be saved?
How much will be saved, patient health... his diapragm is extremely, critically weak from having a machine force breathe for him and be prone under sedation all this time. The amount of PT he will face on the other side of this is extremely daunting.. months of therapy, almost guaranteed.
There's also a need for cash by a fledgling company.. cash to initiate and complete studies on a long, long list of indications that Leronlimab may be effective for... does it do HIV, Cancer, NASH, HVG, Crohn's, etc sufferers any good if Cytodyn saves the world but they're left to suffer and possibly die for a few more years because the US government decided to give $500 million to a company that will fail to produce a vaccine instead of Cytodyn? Or Cytodyn charges too little for Leronlimab and has to keep going to the markets for capital raises?
I'm inclined to say that $4,000 + a dose would be on the high side. $1,200 however is so extremely reasonable, for the US. If it's a one-shot cure, even more so.
How much will be saved, treatment time, facilities, equipment, by Leronlimab?
A friend of mine has been on a ventilator for over six weeks now. I've been trying for months to get his spouse to insist on Leronlimab but she's allowing the doctors to dismiss her... had they gotten an EIND back in April, how much time and resources would be saved?
How much will be saved, patient health... his diapragm is extremely, critically weak from having a machine force breathe for him and be prone under sedation all this time. The amount of PT he will face on the other side of this is extremely daunting.. months of therapy, almost guaranteed.
There's also a need for cash by a fledgling company.. cash to initiate and complete studies on a long, long list of indications that Leronlimab may be effective for... does it do HIV, Cancer, NASH, HVG, Crohn's, etc sufferers any good if Cytodyn saves the world but they're left to suffer and possibly die for a few more years because the US government decided to give $500 million to a company that will fail to produce a vaccine instead of Cytodyn? Or Cytodyn charges too little for Leronlimab and has to keep going to the markets for capital raises?
I'm inclined to say that $4,000 + a dose would be on the high side. $1,200 however is so extremely reasonable, for the US. If it's a one-shot cure, even more so.
4
